Category 2 Placement: The FDA placed BPC-157 in Category 2 of the 503A bulk drug substances list, citing "significant safety concerns." This effectively blocked compounding pharmacies from preparing BPC-157 formulations for patients
Applications include investigating type 2 diabetes prevention, insulin resistance mechanisms, and novel therapeutic approaches for metabolic dysfunction through enzymatic pathway modulation
Repeat the process for the other nostril if your research protocol calls for it
Med spas and aesthetic clinics Med spas offering peptide therapies operate at the intersection of three regulatory frameworks: state medical practice law, FDA drug compounding rules, and the Corporate Practice of Medicine doctrine (CPOM), which governs who can own and control a medical practice
VIP is known for its diverse functions, including the regulation of circadian rhythms, neurotransmission, immune responses, and gastrointestinal motility